BRIEF published on 10/07/2026 at 08:26, 1 month 11 days ago Valerio Therapeutics: Review of the First Half of 2026 Financial Results Valerio Therapeutics Etherna Acquisition Abivax Collaboration InVimmune
BRIEF published on 08/24/2026 at 08:05, 2 months 25 days ago Valerio Therapeutics Acquires Etherna and Secures Financing Valerio Therapeutics Etherna Immunotherapies RNA Therapeutics Acquisition PIPE Financing Biotech Integration
PRESS RELEASE published on 08/24/2026 at 08:00, 2 months 25 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Valerio Therapeutics announces acquisition of Etherna Immunotherapies for €30 million enterprise value and €40.25 million PIPE financing. Shareholder approval secured Acquisition Valerio Therapeutics RNA Therapeutics Etherna Immunotherapies PIPE Financing
BRIEF published on 07/16/2026 at 09:12, 4 months 2 days ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
BRIEF published on 07/16/2026 at 09:12, 4 months 2 days ago Valerio Therapeutics Partners with Abivax for RNA Therapeutics Development Biotechnology Valerio Therapeutics Pipelines RNA Therapeutics Abivax Collaboration
PRESS RELEASE published on 07/16/2026 at 09:07, 4 months 2 days ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
BRIEF published on 07/01/2026 at 09:27, 4 months 17 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
BRIEF published on 07/01/2026 at 09:27, 4 months 17 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
PRESS RELEASE published on 07/01/2026 at 09:22, 4 months 17 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
BRIEF published on 06/16/2026 at 19:48, 5 months 2 days ago Valerio Therapeutics Appoints New CEO and Confirms AGM Resolutions Biotechnology CEO Transition Valerio Therapeutics Gilles Besin RNA Medicines
Published on 11/18/2026 at 21:15, 1 hour 59 minutes ago Sparta Capital Ltd. Announces Resumption of Trading
Published on 11/18/2026 at 15:30, 7 hours 44 minutes ago Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
Published on 11/18/2026 at 14:30, 8 hours 44 minutes ago Boron One Announces Non-Binding Heads of Agreement with Multinational Manufacturing Company
Published on 11/18/2026 at 13:35, 9 hours 39 minutes ago ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
Published on 11/18/2026 at 13:30, 9 hours 44 minutes ago NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
Published on 11/18/2026 at 19:30, 3 hours 43 minutes ago LLCP Completes Investment in Empower Technical Services in Partnership with Management
Published on 11/18/2026 at 18:33, 4 hours 41 minutes ago EQS-Adhoc: Medios AG: Medios AG adopts public share buyback program
Published on 11/18/2026 at 18:05, 5 hours 8 minutes ago ALLWYN UNCOVERS 'FEELINGS DEFICIT' AND JOINS FORCES WITH MARIO LOPEZ TO HELP PEOPLE EXPERIENCE MORE FEELINGS THROUGH PLAY
Published on 11/18/2026 at 17:52, 5 hours 21 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 11/18/2026 at 19:14, 3 hours 59 minutes ago Aéroports de Paris S.A - Favourable binding opinion of the French ART
Published on 11/18/2026 at 17:40, 5 hours 34 minutes ago Infotel : 2027 financial information agenda.
Published on 11/18/2026 at 07:45, 15 hours 29 minutes ago Successful pricing of US$ 10 billion of bonds as part of the financing of the PTC acquisition